MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease

N. Nishikawa, T. Hatano, C. Uchida, Y. Ouji, N. Miyamoto, G. Oyama, N. Hattori (Tokyo, Japan)

Meeting: 2022 International Congress

Abstract Number: 821

Keywords: Anxiety, Depression, Parkinson’s

Category: Parkinson's Disease: Psychiatric Manifestations

Objective: To investigate the feasibility and efficacy of online-based Cognitive Behavioral Therapy (CBT) for anxiety in Parkinson’s disease (PD).

Background: Anxiety symptoms in Parkinson’s disease are highly prevalent and often lead to decreased quality of life and tolerability of treatment medications. We have previously shown that CBT improves anxiety symptoms in PD. Because this trial was a single-arm open trial, we needed to demonstrate the efficacy of CBT in an RCT. However, weekly visits for in-person CBT were not feasible due to the Covid-19 outbreak. Online CBT as a treatment for depression, pain, and diabetes has been shown to be as effective as face-to-face CBT. Therefore, we chose to use online small-group CBT.

Method: The study was a randomized, wait-list controlled Trial for 8 sessions of manualized online small-group CBT program. The small group consisted of one clinical psychologist and four PD patients. The primary endpoint was defined as the degree of improvement of HAM-A (Hamilton Anxiety Scale), and the secondary endpoint was evaluated by the degree of improvement of HAM-D (Hamilton Depression Scale), GAD-7 (Generalized Anxiety Disorder -7), PHQ-9(Patient Health Questionnaire-9), and PDQ39(Parkinson’s Disease Questionnaire-39).
After registering in the clinical trial registration system (UMIN000044247), we obtained approval from the Research Ethics Committee, Faculty of Medicine, Juntendo University (H20-0080) to launch this clinical study.

Results: 32 PD with anxiety symptoms enrolled and 28 of them completed the study. Of the 4 who dropped out, 1 withdrew from the study, 2 discontinued due to worsening depressive symptoms during the waiting period, and 1 discontinued due to surgery for a comorbidity. In the RCT, there was no significant difference in HAM-A improvement between the CBT group and the waiting group. Comparing before and after CBT intervention, there was no difference in improvement in HAM-A, but significant improvement in HAM-D and PDQ-39.

Conclusion: Small group online CBT led by a clinical psychologist was feasible at the Corona Vortex. It did not significantly improve anxiety in PD, but did improve depression and quality of life.

To cite this abstract in AMA style:

N. Nishikawa, T. Hatano, C. Uchida, Y. Ouji, N. Miyamoto, G. Oyama, N. Hattori. A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/a-randomized-wait-list-controlled-trial-of-the-feasibility-and-efficacy-of-small-group-online-based-cognitive-behavioral-therapy-for-anxiety-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-randomized-wait-list-controlled-trial-of-the-feasibility-and-efficacy-of-small-group-online-based-cognitive-behavioral-therapy-for-anxiety-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley